Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.

Myeloma research team at Dana-Farber among the world’s best!

Home/Inspirational, Research, Transplants/Myeloma research team at Dana-Farber among the world’s best!

Myeloma research team at Dana-Farber among the world’s best!

Melanie Graham from Dana-Farber contacted me last week to let me know about an article featuring Dr. Anderson, Dr. Richardson and their colleague, Dr. Nikhil Munshi.  Myeloma geeks like me know that Ken Anderson and Paul Richardson are two of the most renowned myeloma specialists in the world.  If they made sets of baseball cards featuring myeloma docs instead, their cards would be most sought after; like Micky Mantle and Willie Mays!

Take a look at an excerpt from the article:

New Therapies Bring Progress Against Multiple Myeloma

JULY 18th, 2013 – By Christine Cleary

The 21st century has seen great strides in treatment for multiple myeloma, a cancer of the bone marrow once considered a death sentence. In fact, thanks to research by Dana-Farber scientists, this blood cancer that took the lives of Geraldine Ferraro and Leonard P. Zakim has become a chronic disease for many patients.

Left to right: Multiple myeloma leaders Paul Richardson, Nikhil Munshi, and Ken Anderson

Left to right: Multiple myeloma leaders Paul Richardson, Nikhil Munshi, and Ken Anderson

Ken Anderson, MD, and his colleagues have helped transform multiple myeloma into a more manageable illness by shepherding many novel drugs from the laboratory to the patient bedside.

Over a decade ago, median survival in multiple myeloma was just 2 to 3 years. Today, James (Jim) Bond of Cleveland, Ohio, who bicycles across his home state every year to raise money for cancer research, has been Living with Multiple Myeloma for 20 years. Bond credits Dana-Farber’s clinical trials for his longevity.

JIm and his lovely wife, Kathleen

Jim and his lovely wife, Kathleen

I have written about my good friend and fellow survivor, Jim Bond, before:

* Patient Snapshot: 21 year survivor, Jim Bond (Part One)

* Patient Snapshot: 21 year survivor Jim Bond (Part Two)

* Patient Snapshot Updates: John Knighten and Jim Bond

* Patient Snapshot Update: Transplant warriors Mark Parsons, Richard Blustein and Jim Bond


Jim is currently recovering from an allo (donor) stem cell transplant.  But he feels good enough to participate in his fundraising bicycle ride again this summer.  Surviving all of those transplants and still being alive 20 years later?  Maybe Jim deserves his own special myeloma card, too!  Batter up!

The article credits the Dana-Farber team with helping to develop Velcade, Thalomid, Revlimid, Pomalyst and safer stem cell transplant innovations, to mention just a few.  Here’s a link:

One thing that makes this group at Dana-Farber so unique; splitting time between research and patients, giving them a cutting-edge perspective.  Keep up the great work, gentlemen!  Our lives depend upon it.

Feel good and keep smiling!  Pat